Development and clinical use of the new
β
AndrΓ© Reyntjens; Marleen Verlinden; Tonny Aerts
π
Article
π
1986
π
John Wiley and Sons
π
English
β 730 KB
Cisapride is a new gastrointestinal prokinetic substance that is devoid of antidopaminergic and direct muscarinic activity. This was evidenced by a lack of effect on prolactin release and gastric secretion. In man, cisapride stimulates lower esophageal, gastric, small intestinal, and colonic motilit